Barclays slashes price target on Moderna Inc [MRNA] – find out why.
Moderna Inc [NASDAQ: MRNA] closed the trading session at $35.53. The stocks have a year to date performance of -14.55 percent and weekly performance of 11.31 percent. The stock has been moved at -59.13 percent over the last six months. The stock has performed -7.71